ArticleJournal of nanobiotechnology2022

Targeting Myd88 using peptide-loaded mesenchymal stem cell membrane-derived synthetic vesicles to treat systemic inflammation.

Kyong-Su Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.